Cardiovascular and renal benefits of sodium-glucose cotransporter-2 inhibitors: pathophysiologic mechanisms and clinical evidence.
Saved in:
| Title: | Cardiovascular and renal benefits of sodium-glucose cotransporter-2 inhibitors: pathophysiologic mechanisms and clinical evidence. |
|---|---|
| Authors: | Small AM; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Wiviott SD; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA - swiviott@bwh.harvard.edu. |
| Source: | Minerva cardiology and angiology [Minerva Cardiol Angiol] 2024 Nov 20. Date of Electronic Publication: 2024 Nov 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Minerva medica Country of Publication: Italy NLM ID: 101776555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2724-5772 (Electronic) Linking ISSN: 27245683 NLM ISO Abbreviation: Minerva Cardiol Angiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2724-5772 |
|---|---|
| DOI: | 10.23736/S2724-5683.24.06600-6 |
